Publishing research using ab51156? Please let us know so that we can cite the reference in this datasheet.

ab51156 has been referenced in 16 publications.

  • Ma L  et al. Trap Effect of Three-Dimensional Fibers Network for High Efficient Cancer-Cell Capture. Adv Healthc Mater 4:838-43 (2015). PubMed: 25645204
  • Zhang W  et al. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1. Oncotarget 6:5253-62 (2015). WB ; Human . PubMed: 25650660
  • Huang S  et al. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy. J Cell Mol Med 19:608-19 (2015). WB . PubMed: 25583328
  • Xiao G  et al. The metal transporter ZIP13 supplies iron into the secretory pathway in Drosophila melanogaster. Elife 3:e03191 (2014). IHC, ICC/IF . PubMed: 25006035
  • Tseng YY  et al. PVT1 dependence in cancer with MYC copy-number increase. Nature 512:82-6 (2014). WB ; Mouse . PubMed: 25043044
  • van der Meer R  et al. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clin Cancer Res 20:3211-21 (2014). PubMed: 24771642
  • Izumi H & Kaneko Y Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells. Cancer Res 74:5620-30 (2014). PubMed: 25100564
  • Adler AS  et al. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 72:2129-39 (2012). WB, ICC . PubMed: 22345154
  • Winter GE  et al. Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. Nat Chem Biol 8:905-12 (2012). PubMed: 23023260
  • Lucas CM  et al. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 117:6660-8 (2011). ELISA ; Human . PubMed: 21490338
  • Christensen DJ  et al. SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target. Blood 118:4150-8 (2011). PubMed: 21844565
  • Wang J  et al. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene 29:2477-87 (2010). WB ; Mouse . PubMed: 20140016
  • Lee SH  et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 16:665-70 (2010). WB ; Human . PubMed: 20473309
  • Heine VM  et al. Dexamethasone destabilizes Nmyc to inhibit the growth of hedgehog-associated medulloblastoma. Cancer Res 70:5220-5 (2010). WB ; Mouse . PubMed: 20530674
  • Seo HR  et al. Cdk5-mediated Phosphorylation of c-Myc on Ser-62 Is Essential in Transcriptional Activation of Cyclin B1 by Cyclin G1. J Biol Chem 283:15601-15610 (2008). WB ; Human . PubMed: 18408012
  • Zhang Y  et al. Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 27:4809-19 (2008). WB ; Human . PubMed: 18438430